This proposed rule focuses primarily on PMTA overview treatments and content needs, notably with respect to software acceptance and filing. An software may perhaps fulfill the acceptance and filing necessities, but still lack vital data that FDA needs to find out no matter if it ought to concern a marketing and advertising purchase. The proposed ru